Book Value per Share: Galmed Pharma (GLMD)

Graphic logo of Galmed Pharmaceuticals Ltd. (GLMD)

Portfolio restructuring toward fibrosis treatment creates fierce competition for capital, which is evidenced by the volatility of the book value per share for Galmed Pharmaceuticals (GLMD). The latest value is recorded as 12.62. Brand stability is based on the safety of the Aramchol molecule and successes in treating orphan diseases. Market confidence is further bolstered by a unique platform for NAFLD therapy.

Galmed Pharma (GLMD): Share Book Value from 07/04/2022 to 09/10/2026

Galmed Pharmaceuticals Ltd - analytical breakdowns and key metrics (GLMD)

- price and consensus price forecast:
Price Chart Galmed Pharma|GLMD - Consensus Target
- market capitalization data:
Market Capitalization Galmed Pharmaceuticals Ltd.|GLMD - Business Value
- book capitalization data:
Net Assets per Single Share Galmed Pharmaceuticals|GLMD - Net Asset Value|Market Capitalization to Book Value Ratio galmedpharma.com|GLMD - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Galmed Pharmaceuticals|GLMD - Long-Term Debt to Capital|Short-Term Debt to Equity Galmed Pharma|GLMD - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Galmed Pharmaceuticals Ltd.
Fundamental company valuation:galmedpharma.com - GLMD
Manufactured products of Galmed Pharma

Galmed Pharmaceuticals' focus on developing combination therapies for liver diseases requires significant capital expenditures, which is reflected in the BVPS valuation via equity dynamics minus liabilities. Under US GAAP standards, this indicator measures the net asset value per share, allowing investors to compare the company's actual asset value against market risks and the effectiveness of management's scientific strategy.

Competitors of Galmed Pharmaceuticals (GLMD)

ARWR: Net Assets per Single Share|MIRM - Accounting Value per Share|Book Value per Share Dynavax Pharma|ABUS (arbutusbio.com) - Equity per Share|Net Assets per Single Share Inventiva IVA|Share Book Value Gyre Therapeutics Inc|Assembly Biosciences Inc (ASMB) - Book Value per Share|Accounting Value of a Share galectintherapeutics.com (GALT)|Book Value per Share GNFT (GENFIT)|DURECT Corp - Book Value per Share|Net Assets per Single Share Aligos (ALGS)|BIVI: Accounting Value of a Share|NDRA (ENDRA) - Net Assets per Single Share|Hepion Pharmaceuticals, Inc. (HEPA) - Accounting Value per Share